News in brief

FDA to transition to new portal for NDI, structure/function submissions

By Hank Schultz

- Last updated on GMT

Getty Images
Getty Images
Companies submitting NDIs and structure/function claims will see a different interface starting on Friday, the US Food and Drug Administration announced today.

FDA calls the new system the CFSAN Online Submission Module (COSM). It will replace the current electronic submission system, known as the FDA Unified Registration Listing System (FURLS). Companies that have been using FURLS for New Dietary Ingredient Notifications and Structure/Function Claims Notifications (SFCN) will use the new system from now on.

According to FDA, starting on Friday, Sept. 6:

1.  All system users will see a new interface when accessing the electronic portal for NDIN and SFCN submissions; and

2.  User information previously stored in the FURLS database, including login information, will automatically be transferred to the new electronic submission portal in COSM. 

The agency added that if companies have a submission pending in FURLS at the moment, they will have 30 days to complete that process.  After that, the submission will have to be re entered using the COSM system.

For assistance in completing existing submissions, users can contact FDA at SHEYFFhccbeg@sqn.uuf.tbi​.

Related news

Show more

Related products

show more

New postbiotic for gut & skin health benefits

New postbiotic for gut & skin health benefits

Content provided by Kerry ProActive Health | 14-May-2024 | Product Presentation

Plenibiotic™ (Lactobacillus casei subsp. casei 327) is a rice-derived postbiotic providing a holistic approach to digestive and skin health. It offers...

Redefine resilience with IMMUSE

Redefine resilience with IMMUSE

Content provided by Kyowa Hakko (US) | 02-May-2024 | White Paper

IMMUSETM is a universal postbiotic — the first of its kind to activate pDC cells for year-round immune support.

Related suppliers

Follow us

Products

View more

Webinars